News | April 24, 2015

Making Waves with Robotic Ultrasound Between New York and Chicago

Icahn School of Medicine, Rush University Medical Center testing long-distance, tele-robotic ultrasound over the Internet

Icahn School of Medicine, Mount Sinai, Rush, tele-robotic ultrasound, telehealth

April 24, 2015 – A new clinical trial is testing the feasibility and efficiency of a doctor in New York City remotely performing long-distance, tele-robotic ultrasound exams over the Internet on patients in Chicago.

The study is a research collaboration between cardiovascular imaging specialists of Icahn School of Medicine at Mount Sinai in New York and Rush University Medical Center in Chicago.

The research team is investigating if remote, long-distance tele-robotic ultrasound exams of the carotid artery in the neck could be just as efficient as traditional, in-person manual ultrasound exams to test for signs of carotid intima-media thickness and carotid atherosclerotic plaque; both conditions are risk factors for cardiovascular events such as heart attack and stroke.

The study, enrolling 100 participants over the age of 60 in Chicago at Rush, is using a small, robotic arm outfitted with ultrasound technology and connected to a personal computer with a standard Internet connection. The robot is controlled over the Internet by a Mount Sinai cardiovascular specialist with the ability to complete a scan of the carotid artery in just 4 minutes. In addition, each patient will also receive a manual, in-person ultrasound exam by Rush to compare detection results.

“Launching long-distance, tele-robotic ultrasound exams between two major hospitals in two large cities is a sign that we may be able to make waves in accelerating access to and cost-effectiveness of this critical heart health imaging diagnostic tool to other cities, small towns, or rural communities in need,” said Partho P. Sengupta, M.D., the study’s principal investigator at Mount Sinai and director of interventional echocardiography and cardiac ultrasound research, and associate professor of medicine (cardiology) at Icahn School of Medicine at Mount Sinai.

“Imaging technology is evolving at a rapid pace. If this tele-health breakthrough proves feasible and successful it may open the door for more accessible screening, prevention, and diagnostic capabilities for patients who may be at high-risk for cardiovascular diseases,” said Rami Doukky, M.D., MSc, the study’s principal investigator at Rush, professor of medicine and radiology at Rush Medical College and the interim chief of cardiology at the John H. Stroger, Jr. Hospital of Cook County in Chicago.

“Our platform brings together remotely controllable robotics, ultrasound and telepresence to allow an experienced operator located anywhere in the world to perform an ultrasound exam at a distance,” said Jeffrey Soble, M.D., associate professor of cardiology at Rush University Medical Center. Soble is one of the creators of the novel tele-robotic healthcare technology being tested called TRUDI (Tele-Robotic Ultrasound for Distance Imaging), a product of the company TeleHealthRobotics which he co-founded with biomedical engineer Sarah Doherty.

This new pioneering clinical trial in the United States, builds upon the recent research breakthrough collaboration of Mount Sinai and TeleHealthRobotics’ technology using remote, long-distance robotic-assisted ultrasound imaging internationally.

While in Germany, Mount Sinai’s Sengupta used TRUDI to perform the first robot-assisted trans-Atlantic ultrasound examination on a person in Boston. “Our successful first-in-man international experiment opened up a new frontier for the use of remote, robotic ultrasound imaging that could potentially be more efficient and cost-effective overall for healthcare delivery,” said Sengupta.

In addition, Mount Sinai and collaborators in Sweden tested the feasibility of similar tele-robotic ultrasound technology within Sweden for heart failure patients at a remote primary care center located a far distance from the nearest Swedish hospital. “Our tele-robotic ultrasound approach reduced the time to care and improved patient satisfaction substantially,” said Jagat Narula, M.D., Ph.D., that study’s senior investigator and Mount Sinai’s director of cardiovascular imaging.

“Our recent research breakthroughs give us a glimpse of what to expect in the near future — a patient-friendly imaging technology at your doorstep,” added Narula.

Valentin Fuster, M.D., Ph.D., director of Mount Sinai Heart at Mount Sinai says: “Tele-robotic imaging may be the key ‘helping hand’ we need to accelerate greater local and global healthcare access.”

For more information: www.mountsinai.org

Related Content

Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Philips Launches Latest Iteration of IntelliSpace Cardiovascular at HIMSS 2019
Technology | Cardiac PACS | February 13, 2019
Philips announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
Epiq Elite for Obstetrics and Gynecology delivers high image quality and lifelike 3-D scans

The Epiq Elite for Obstetrics & Gynecology. Image courtesy of Philips Healthcare.

Technology | Ultrasound Imaging | February 07, 2019
Philips announced the launch of the Epiq Elite ultrasound system, a new premium ultrasound that combines the latest...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi
Konica Minolta Releases Sonimage HS1 Ultrasound Software Upgrade
News | Ultrasound Imaging | January 31, 2019
Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
ASE Releases New Guide to Performing Comprehensive Transthoracic Echo Exams
News | Cardiovascular Ultrasound | January 21, 2019
January 21, 2019 – Medical experts have released “...